{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000142","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.926143+00:00","generated_at":"2026-05-17T04:35:15.628457+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"confidence":"high","headline":"Salarius raises $6.2M; believes Nasdaq equity compliance regained ahead of Oct 20 deadline","bullets":["Raised $2.4M from ATM sales (434,882 shares) and $3.8M from C/M Capital Master Fund purchase agreement.","Believes stockholders' equity now exceeds $2.5M as of Oct 6, 2025; awaiting Nasdaq confirmation.","Previously faced Nasdaq delisting risk if compliance not met by Oct 20, 2025.","Q3 10-Q expected to reflect equity above $2.5M as of Sept 30, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000142","json":"https://secwatch.observer/filing/0001615219-25-000142.json","markdown":"https://secwatch.observer/filing/0001615219-25-000142.md","text":"https://secwatch.observer/filing/0001615219-25-000142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000142/0001615219-25-000142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000142/flks-20251006.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:35:15.628457+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}